NCT01526122View on ClinicalTrials.gov

Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration

PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Atherosclerosis
Interventions
DRUG

G0041(75/100mg)

G0041(75/100mg) 2 capsules(Clopidogrel 75mg \& Aspirin 100mg in 1 capsule), PO

DRUG

Clopidogrel & Aspirin

Clopidogrel 75mg 2 tablets \& Aspirin 100mg 2 capsules, PO

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT01526122 - Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration | Biotech Hunter | Biotech Hunter